EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Yiyi Fuzi Baijiang Powder Alleviates Dextran Sulfate Sodium-Induced Ulcerative Colitis in Rats via Inhibiting the TLR4/NF-κB/NLRP3 Inflammasome Signaling Pathway to Repair the Intestinal Epithelial Barrier, and Modulating Intestinal Microbiota

Jinguang Yang iD, Lili Miao iD, Ye Xue iD, Xiaoyan Wang iD

Oxidative Medicine and Cellular Longevity · 2023

DOI: 10.1155/2023/3071610 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Oxidative Medicine and Cellular Longevity, 2023. Verfasst von Jinguang Yang und 3 weiteren Autor:innen. Beteiligte Einrichtung: The First Clinical Medical College, Shandong University of Traditional Chinese Medicine, Jinan, Shandong, China. Hauptthemen laut MEDLINE: Colitis, Ulcerative, Gastrointestinal Microbiome. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 73 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Shandong University, Scientific and Technological Development Plan of Traditional Chinese Medicine of Shandong Province.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Ulcerative colitis (UC) is a chronic non-specific inflammatory disease of the intestine, which is prone to recurrence and difficult to cure. Yiyi Fuzi Baijiang powder (YFBP), as a classic Chinese herbal formula, is commonly used in the clinical treatment of UC. However, its potential mechanism remains unclear. In this study, we investigated the mechanism by which YFBP exerts a therapeutic effect against UC. Firstly, we used network pharmacology to screen the active ingredients and potential targets of YFBP and constructed a “drug-ingredient-target” network. Based on bioinformatics, we searched for differentially expressed genes (DEGs) associated with UC and obtained common targets. The core targets of YFBP in the treatment of UC were identified using a protein-protein interaction (PPI) network, and molecular docking techniques were used to evaluate the binding energies of the core targets and corresponding ingredients. Enrichment analysis by Gene Ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG) revealed that YFBP exerted therapeutic effects by regulating multiple inflammatory pathways including TLR4, NF-κB, and TNF. Secondly, an experimental study was carried out in vivo for verification. Our results demonstrated that YFBP could effectively improve the symptoms and intestinal pathological of UC rats. Further study showed that YFBP could significantly downregulate the expressions of TLR4 and p-NF-κB p65 in UC rats, inhibit the activation of NLRP3 inflammasome, reduce the levels of IL-1β and TNF-α, and then upregulate the expressions of tight junction proteins in intestinal epithelial cells. In addition, YFBP could improve the intestinal microbial community. In conclusion, our study revealed that YFBP had a good therapeutic effect on UC, and its mechanism might be related to the inhibition of the TLR4/NF-κB/NLRP3 inflammasome signaling pathway to repair intestinal epithelial barrier and the modulation of intestinal microbiota.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Colitis, UlcerativeGastrointestinal MicrobiomeRatsAnimalsNF-kappa BInflammasomesNLR Family, Pyrin Domain-Containing 3 ProteinDextran SulfateToll-Like Receptor 4PowdersMolecular Docking SimulationSignal TransductionIntestinesDiterpenesDrugs, Chinese Herbal

Substanzen

NF-kappa BInflammasomesNLR Family, Pyrin Domain-Containing 3 ProteinDextran SulfateToll-Like Receptor 4Powdersfuzi drug herbalDiterpenesDrugs, Chinese HerbalTlr4 protein, rat

Autor:innen und Institutionen

  • The First Clinical Medical College, Shandong University of Traditional Chinese Medicine, Jinan, Shandong, China.
  • Experimental Center of Shandong University of Traditional Chinese Medicine, Jinan, Shandong, China.
  • College of Traditional Chinese Medicine, Shandong University of Traditional Chinese Medicine, Jinan, Shandong, China.

ORCID-Profile: Jinguang Yang, Lili Miao, Ye Xue, Xiaoyan Wang

Förderung

  • Shandong University
  • Scientific and Technological Development Plan of Traditional Chinese Medicine of Shandong Province

Zitieren

APA

Yang, J., Miao, L., Xue, Y., & Wang, X. (2023). Yiyi Fuzi Baijiang Powder Alleviates Dextran Sulfate Sodium-Induced Ulcerative Colitis in Rats via Inhibiting the TLR4/NF-κB/NLRP3 Inflammasome Signaling Pathway to Repair the Intestinal Epithelial Barrier, and Modulating Intestinal Microbiota. Oxidative Medicine and Cellular Longevity. https://doi.org/10.1155/2023/3071610

Vancouver

Yang J, Miao L, Xue Y, Wang X. Yiyi Fuzi Baijiang Powder Alleviates Dextran Sulfate Sodium-Induced Ulcerative Colitis in Rats via Inhibiting the TLR4/NF-κB/NLRP3 Inflammasome Signaling Pathway to Repair the Intestinal Epithelial Barrier, and Modulating Intestinal Microbiota. Oxidative Medicine and Cellular Longevity. 2023. doi:10.1155/2023/3071610

BibTeX
@article{Yang2023,
  author = {Yang, Jinguang and Miao, Lili and Xue, Ye and Wang, Xiaoyan},
  title = {Yiyi Fuzi Baijiang Powder Alleviates Dextran Sulfate Sodium-Induced Ulcerative Colitis in Rats via Inhibiting the TLR4/NF-κB/NLRP3 Inflammasome Signaling Pathway to Repair the Intestinal Epithelial Barrier, and Modulating Intestinal Microbiota},
  journal = {Oxidative Medicine and Cellular Longevity},
  year = {2023},
  doi = {10.1155/2023/3071610}
}
Kostenlos starten →